| 包装 | 价格(元) |
| 100uL/well(10 mM solution),96 Well Deep Well Plate | 电议 |
| 100uL/well(10 mM solution),96 Well Racks With Screw Cap | 电议 |
| 250uL/well(10 mM solution),96 Well Racks With Screw Cap | 电议 |
| Catalog No. | Product Name | Summary | Targets | CAS Number | Smiles |
| A3146 | AGI-6780 | IDH2/R140Q mutation inhibitor | Dehydrogenase | 1432660-47-3 | C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F |
| A3536 | L-165041 | PPARβ/δ agonist,cell permeable,potent and selective | PPAR | 79558-09-1 | CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=CC=C(C=C2)OCC(=O)O |
| A4339 | AGI-5198 | IDH1 inhibitor against R132 mutant,selective and cell-permeable | Dehydrogenase | Dehydrogenase | CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C |
| A4367 | Atorvastatin Calcium | HMG-CoA reductase inhibitor | HMG-CoA Reductase | 134523-03-8 | CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O- |
| A4373 | NLG919 | Potent IDO pathway inhibitor | IDO | 1402836-58-1 | C1CCC(CC1)C(CC2C3=CC=CC=C3C4=CN=CN24)O |
| A4388 | XL-888 | Hsp90 inhibitor | HSP | 1149705-71-4 | CCC(C)NC1=CC(=C(C=C1C(=O)N)C)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5 |
| B1788 | Mevastatin | HMG-CoA reductase inhibitor | HMG-CoA Reductase | 73573-88-3 | CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O |
| B7794 | BMS 309403 | FABP4 inhibitor,potent and selective | Lipid Metabolism | 300657-03-8 | OC(COC1=CC(C2=CC=CC=C2N3N=C(C4=CC=CC=C4)C(C5=CC=CC=C5)=C3CC)=CC=C1)=O |
| Form | Pre-dissolved DMSO solutions | Stability | Solution: -20°C for 12 months, -80°C for 24 months |
| Packaging | 96-well DeepWell format with peelable foil seal and EVA cap (100 μL/well, 10 mM DMSO). 96-well rack with Matrix 2D Barcoded ScrewTop Storage tubes (250 μL or 100 μL/well, 10 mM DMSO). | ||
| Shipping Condition | Evaluation sample solution: ship with blue ice All other available size: ship with RT, or blue ice upon request | ||


